Cargando…

CD40-Mediated Amplification of Local Immunity by Epithelial Cells Is Impaired by HPV

The interaction between the transmembrane glycoprotein surface receptor CD40 expressed by skin epithelial cells (ECs) and its T-cell–expressed ligand CD154 was suggested to exacerbate inflammatory skin diseases. However, the full spectrum of CD40-mediated effects by ECs underlying this observation i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tummers, Bart, Goedemans, Renske, Jha, Veena, Meyers, Craig, Melief, Cornelis J M, van der Burg, Sjoerd H, Boer, Judith M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227541/ https://www.ncbi.nlm.nih.gov/pubmed/24945092 http://dx.doi.org/10.1038/jid.2014.262

Ejemplares similares

Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFNγ- and TNFα-Mediated Antiproliferative Effects and Necroptosis
por: Ma, Wenbo, et al.
Publicado: (2016)

The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation
por: Tummers, Bart, et al.
Publicado: (2015)

Human Papillomavirus (HPV) Upregulates the Cellular Deubiquitinase UCHL1 to Suppress the Keratinocyte's Innate Immune Response
por: Karim, Rezaul, et al.
Publicado: (2013)

Human Papillomavirus Deregulates the Response of a Cellular Network Comprising of Chemotactic and Proinflammatory Genes
por: Karim, Rezaul, et al.
Publicado: (2011)

High-Risk Human Papillomavirus Targets Crossroads in Immune Signaling
por: Tummers, Bart, et al.
Publicado: (2015)

Spontaneous tumor rejection by cbl-b–deficient CD8(+) T cells
por: Loeser, Stefanie, et al.
Publicado: (2007)

Synergy between chemotherapy and cancer vaccination
por: van der Sluis, Tetje C., et al.
Publicado: (2015)

Enforced OX40 Stimulation Empowers Booster Vaccines to Induce Effective CD4(+) and CD8(+) T Cell Responses against Mouse Cytomegalovirus Infection
por: Panagioti, Eleni, et al.
Publicado: (2017)

A Critical Role for Cd40–Cd40 Ligand Interactions in Amplification of the Mucosal Cd8 T Cell Response
por: Lefrançois, Leo, et al.
Publicado: (1999)

Synergy of therapeutic vaccination against HPV16 oncogenic proteins and standard chemotherapeutics
por: Melief, Cornelis J, et al.
Publicado: (2014)

Differential Dependence on Host Cell Glycosaminoglycans for Infection of Epithelial Cells by High-Risk HPV Types
por: Cruz, Linda, et al.
Publicado: (2013)

Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer
por: van Poelgeest, Mariëtte I. E., et al.
Publicado: (2016)

TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients
por: Zom, Gijs G., et al.
Publicado: (2016)

The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools
por: Singh, Satwinder Kaur, et al.
Publicado: (2012)

A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer
por: Dijkgraaf, Eveline M., et al.
Publicado: (2015)

Peptide emulsions in incomplete Freund’s adjuvant create effective nurseries promoting egress of systemic CD4(+) and CD8(+) T cells for immunotherapy of cancer
por: Melssen, Marit M, et al.
Publicado: (2022)

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
por: van Poelgeest, Mariette I E, et al.
Publicado: (2013)

Delayed vaccine-induced CD8(+) T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradication
por: van der Sluis, Tetje C, et al.
Publicado: (2023)

IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma
por: Melief, Sara M., et al.
Publicado: (2017)

Human immunodeficiency virus and human papilloma virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful
por: van der Burg, Sjoerd H, et al.
Publicado: (2009)

A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency
por: Punt, Simone, et al.
Publicado: (2016)

Generating HPV specific T helper cells for the treatment of HPV induced malignancies using TCR gene transfer
por: Scholten, Kirsten BJ, et al.
Publicado: (2011)

CD40–CD40L in Neurological Disease
por: Ots, Heather D., et al.
Publicado: (2022)

KLF10 Mediated Epigenetic Dysregulation of Epithelial CD40/CD154 Promotes Endometriosis
por: Delaney, Abigail A., et al.
Publicado: (2016)

A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
por: de Vos van Steenwijk, Peggy J., et al.
Publicado: (2012)

CD4 T Cells and Their Role in Antitumor Immune Responses
por: Toes, René E.M., et al.
Publicado: (1999)

Molecular Mimicry of Human Cytochrome P450 by Hepatitis C Virus at the Level of Cytotoxic T Cell Recognition
por: Kammer, Andreas R., et al.
Publicado: (1999)

Cell mediated immunity against HPV16 E2, E6 and E7 peptides in women with incident CIN and in constantly HPV-negative women followed-up for 10-years
por: Paaso, Anna, et al.
Publicado: (2015)

Staphylococcal Superantigens Stimulate Epithelial Cells through CD40 To Produce Chemokines
por: Schlievert, Patrick M., et al.
Publicado: (2019)

Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions
por: Speetjens, Frank M, et al.
Publicado: (2022)

The combined HPV16-E2/E6/E7 T cell response in oropharyngeal cancer predicts superior survival
por: Santegoets, Saskia J., et al.
Publicado: (2023)

CD40 in Clinical Inflammation: From Multiple Sclerosis to Atherosclerosis
por: Laman, Jon D., et al.
Publicado: (1998)

Residue-Specific Message Encoding in CD40-Ligand
por: Sarode, Aditya Yashwant, et al.
Publicado: (2020)

CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors
por: Duurland, Chantal L, et al.
Publicado: (2022)

The Human Papillomavirus (HPV) E6 Oncoprotein Regulates CD40 Expression via the AT-Hook Transcription Factor AKNA
por: Manzo-Merino, Joaquin, et al.
Publicado: (2018)

Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines
por: Çuburu, Nicolas, et al.
Publicado: (2022)

Interferon‐γ and IL‐5 associated cell‐mediated immune responses to HPV16 E2 and E6 distinguish between persistent oral HPV16 infections and noninfected mucosa
por: Paaso, Anna, et al.
Publicado: (2021)

A qualitative study of parental associations and beliefs regarding the HPV vaccination for Dutch boys
por: Venderbos, Judith R., et al.
Publicado: (2022)

CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8(+) T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication
por: Zhang, Yanmei, et al.
Publicado: (2020)

Adipocytes in their (CD)40s
por: Bertola, Adeline, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ac8857dof8t235cp3kn6kcf4m2